Therapy News and Research

RSS

Second Peace Corps volunteer reports being discharged after testing HIV-positive, Washington Post reports

Washington Post columnist Stephen Barr on Friday examined the case of a second Peace Corps volunteer who said she was discharged from service after testing HIV-positive. Rebecca Coulborn, a former volunteer in Burkina Faso, said she was required to leave her post immediately in 2001 after she tested positive for the virus.

19 May 2008

Personalized therapy for asthma and chronic obstructive pulmonary disease could soon be here

Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.

19 May 2008

Nurse-administered prevention and management strategies can decrease incidence of lymphedema and improve quality of life in patients

A poster session presented by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.

19 May 2008

Study finds new generation of drug-coated stent benefits heart patients

A two-year study comparing a new generation drug-coated stent, XIENCE, with a currently used drug eluting stent, TAXUS, has found that the XIENCE stent had superior benefits in more than 1,000 patients and is better at keeping the arteries of chest pain patients clear of blood clots.

15 May 2008

New Wilmot Cancer Center offers expanded care, research for cures

The University of Rochester Medical Center (URMC) today celebrates the expansion of cancer care and research as it dedicates the new James P. Wilmot Cancer Center. The Center introduces leading-edge technology, greater access to multidisciplinary care, a new model for breast care, and more opportunities to receive tomorrow's therapies today.

15 May 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

Remaining stocks of Trasylol removed

On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested an increased risk for death compared to two other drugs used to control bleeding.

15 May 2008

Researchers who helped millions with arthritis receive Janssen Award

Two British researchers who pioneered treatments which have helped millions of people with rheumatoid arthritis and other autoimmune diseases have been awarded the prestigious 2008 Dr. Paul Janssen Award for Biomedical Research, announced today.

13 May 2008

Drug therapy for phenylketonuria reverses heart damage

A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns Hopkins shows.

13 May 2008

Vitamin D protects cells from stress that can lead to cancer

By inducing a specific gene to increase expression of a key enzyme, vitamin D protects healthy prostate cells from the damage and injuries that can lead to cancer, University of Rochester Medical Center researchers report.

13 May 2008

Traffic pollution can be deadly as it increases the risk of deep vein thrombosis

Scientists in the U.S. have confirmed a long held suspicion that traffic pollution can be deadly for some people.

13 May 2008

Beta blockers after surgery more risky than beneficial

The results of new research has shown that patients given high doses of beta blocker drugs following non-cardiac surgery were more likely to have a stroke or die. However they were less likely to suffer a heart attack.

13 May 2008

Arsenic-based agent shown to help eradicate leukemia-initiating cells

In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear responsibility for the disease's reemergence.

12 May 2008

Discovery of gene mutation which causes epilepsy and mental retardation - but only in women

An Australian and British research team have discovered a gene mutation that causes epilepsy and mental retardation but only in women.

12 May 2008

Discovery of mechanism of action of antibiotic able to reduce neuronal cell death in brain

Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.

11 May 2008

Study affirms effectiveness of medication for juvenile rheumatoid arthritis

Juvenile rheumatoid arthritis (JRA) is a chronic autoimmune disease that strikes children between the ages of newborn to 16 years. All children with JRA have joint pain, stiffness, and swelling and some also have fever and skin rashes.

9 May 2008

FDA approves Strattera for ADHD in children and adolescents

Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.

8 May 2008

Skin flaps deliver cancer-fighting therapy

Using gene therapy, plastic surgeons have delivered cancer fighting proteins through skin flaps placed on cancerous tumors on rats with a 79 percent reduction in tumor volume, according to a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

8 May 2008

Medicare fee cuts could devastate rehabilitation services

Pending cuts to the Medicare physician fee schedule could severely hamper the ability of physical therapists to serve the rehabilitation needs of seniors and people with disabilities -- driving up overall costs while decreasing quality of care, according to the American Physical Therapy Association (APTA) and its Private Practice Section.

8 May 2008

ART drugs for pregnant women eradicates baby's risk of HIV

Researchers in Britain say a baby's risk of contracting HIV from its mother can be almost eradicated with the use of antiretroviral drugs.

8 May 2008

Therapy News and Research

Second Peace Corps volunteer reports being discharged after testing HIV-positive, Washington Post reports

Personalized therapy for asthma and chronic obstructive pulmonary disease could soon be here

Nurse-administered prevention and management strategies can decrease incidence of lymphedema and improve quality of life in patients

Study finds new generation of drug-coated stent benefits heart patients

New Wilmot Cancer Center offers expanded care, research for cures

New hay fever jab promises year long relief for sufferers

Remaining stocks of Trasylol removed

Researchers who helped millions with arthritis receive Janssen Award

Drug therapy for phenylketonuria reverses heart damage

Vitamin D protects cells from stress that can lead to cancer

Traffic pollution can be deadly as it increases the risk of deep vein thrombosis

Beta blockers after surgery more risky than beneficial

Arsenic-based agent shown to help eradicate leukemia-initiating cells

Discovery of gene mutation which causes epilepsy and mental retardation - but only in women

Discovery of mechanism of action of antibiotic able to reduce neuronal cell death in brain

Study affirms effectiveness of medication for juvenile rheumatoid arthritis

FDA approves Strattera for ADHD in children and adolescents

Skin flaps deliver cancer-fighting therapy

Medicare fee cuts could devastate rehabilitation services

ART drugs for pregnant women eradicates baby's risk of HIV

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News